Intelligence Β· Patent portfolio
Lxo Ireland Designated Patents
Full USPTO pharma patent portfolio for Lxo Ireland Designated β grant dates, expiration, and drug cross-links.
- Patents
- 201
- Expiring β€24m
- 3
Quick answer
Lxo Ireland Designated has 201 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β use filters for patent-cliff planning.
-
US 7465748
Amide derivative
granted -
US 7411076
Coumarin derivative
granted -
US 7396816
Low-molecular weight peptides inhibiting ion channel activity
granted -
US 7378273
Expression vectors
granted -
US 7252996
Ancillary composition for the preparation of committed mature dentritic cells
granted -
US 7119103
Ξ²3-Adrenoreceptor agonists, agonist compositions and methods of using
granted -
US 7022500
Humanized immunoglobulins
expired -
US 6949543
Amide derivative
expired -
US 6919357
Ξ± adrenergic agents
expired -
US 6903125
Tetrahydro-2H-thiopyran-4-carboxamide derivative
expired -
US 6897052
N-acetylglycosaminyl transferase genes
expired -
US 6894149
Anti-HLA-DA antibodies and the methods of using thereof
expired -
US 6869959
Heterocyclic carboxylic acid derivatives
expired -
US 6838574
Dicarba-closo-dodecarborane derivatives
expired -
US 6825213
&bgr;3-adrenoreceptor agonists, agonist compositions and methods of using
expired -
US 6821516
Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
expired -
US 6818207
Artificial nail compositions and related method
expired -
US 6808707
Wound healing compositions and methods using tropoelastin and lysyl oxidase
expired -
US 6780586
Methods of diagnosing breast cancer
expired -
US 6762020
Methods of diagnosing breast cancer
expired -
US 6737051
Cell compositions containing macrophages, presenting anti-infectious and hematopoietic properties
expired -
US 6713056
Combined preparation for the treatment of neoplasic diseases or of infectious diseases
expired -
US 6703016
Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
expired -
US 6682890
Methods of diagnosing and determining prognosis of colorectal cancer
expired -
US 6616925
Combined preparation for the treatment of neoplasic diseases or of infectious diseases
expired -
US 6613792
Treatment of premenstrual syndrome and menopause
expired -
US 6608238
Trans-somatics with gene transfer into mammary epithelial cells
expired -
US 6599921
Non-steroidal estrogen receptor ligands
expired -
US 6596275
Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions
expired -
US 6593119
Core 2 &bgr;-1,6-N-acetylglycosaminyltransferase gene
expired -
US 6540994
Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
expired -
US 6478379
Chair
expired -
US 6476017
Compounds activating pharmacological effect of retinoids
expired -
US 6458782
Remedies for diabetes
expired -
US 6410824
Animal model for psoriasis for the prevention and treatment of psoriasis in humans
expired -
US 6399372
Monocyte derived cells with immunostimulating properties, their preparation and uses
expired -
US 6395745
Alkaloid halide salts of swainsonine and methods of use
expired -
US 6379905
Fragments of prion proteins
expired -
US 6372499
Polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
expired -
US 6329511
Humanized antibodies to .gamma.-interferon
expired -
US 6262069
1-amino-7-isoquinoline derivatives as serine protease inhibitors
expired -
US 6251858
Derivatives of oligosides, their process of preparation and their applications
expired -
US 6221576
Process for preparing macrophages, kits, and compositions for the use of this process
expired -
US 6214811
Acyclovir diester derivatives
expired -
US 6210671
Humanized antibodies reactive with L-selectin
expired -
US 6210670
Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin
expired -
US 6180370
Humanized immunoglobulins and methods of making the same
expired -
US 6140122
Process for preparing macrophages, kits, and compositions for the use of this process
expired
Frequently asked questions
How many patents does Lxo Ireland Designated have?
201 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Lxo Ireland Designated patents expire?
3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory